Nizoral Anti-dandruff is a drug owned by Kramer Laboratories Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Apr 07, 2014. Details of Nizoral Anti-dandruff's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5456851 | Ketoconazole shampoo containing butylated hydroxytoluene or butylated hydroxyanisole |
Apr, 2014
(10 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Nizoral Anti-dandruff is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Nizoral Anti-dandruff's family patents as well as insights into ongoing legal events on those patents.
Nizoral Anti-dandruff's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Nizoral Anti-dandruff's generic launch date based on the expiry of its last outstanding patent is estimated to be Apr 07, 2014 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Nizoral Anti-dandruff Generic API suppliers:
Ketoconazole is the generic name for the brand Nizoral Anti-dandruff. 17 different companies have already filed for the generic of Nizoral Anti-dandruff, with Teva having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Nizoral Anti-dandruff's generic
Alternative Brands for Nizoral Anti-dandruff
There are several other brand drugs using the same active ingredient (Ketoconazole) as Nizoral Anti-dandruff. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
Apart from brand drugs containing the same ingredient, some generics have also been filed for Ketoconazole, Nizoral Anti-dandruff's active ingredient. Check the complete list of approved generic manufacturers for Nizoral Anti-dandruff
About Nizoral Anti-dandruff
Nizoral Anti-Dandruff is a drug owned by Kramer Laboratories Inc. Nizoral Anti-Dandruff uses Ketoconazole as an active ingredient. Nizoral Anti-Dandruff was launched by Kramer in 1997.
Approval Date:
Nizoral Anti-dandruff was approved by FDA for market use on 10 October, 1997.
Active Ingredient:
Nizoral Anti-dandruff uses Ketoconazole as the active ingredient. Check out other Drugs and Companies using Ketoconazole ingredient
Dosage:
Nizoral Anti-dandruff is available in shampoo form for topical use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 1% | SHAMPOO | Over the counter | TOPICAL |